Fourteen Belgian Blue calves (1–2 years old) naturally infested with P. ovis mites were included in the animal study. Skin scrapings were collected from each animal for mite counts and mite identification on day-7. The CI was determined for each animal by recording the skin lesions (on both sides of the animal) on a silhouette [22 (link)]. Animals were randomly assigned to treatment and control group using CI as stratification factor.
On day 0, all animals in the treatment group were weighed and injected intramuscularly with dexamethasone (MSD Animal Health, Belgium) at a dose of 0.06 mg/kg body weight. Control animals were injected with the same volume of physiological saline (0.9%). On day 7 and day 14, the treatment was repeated.
All animals were followed for 4 weeks, whereby the CI was determined weekly for each animal as described above. Punch biopsies were taken on day 0, day 7 and day 28 from the edge of active lesions, following the administration of a local anaesthetic (3–4 mL 4% procaine hydrochloride and 0.0036% adrenaline tartrate, KELA, S.C.-epidural, Belgium). The 4 mm biopsy was immediately fixed in 4% formaldehyde and paraffin-embedded for histology and immunohistochemistry. At day-7 and day 28 post treatment, P. ovis mites in the active lesions were counted, as described above.
All animals were housed together in a pen on straw bedding, and were provided with corn silage, grass silage and water ad libitum and a daily ration of 1.5–2.0 kg concentrates per animal. All animals were checked weekly for any adverse reactions to the dexamethasone treatment by clinical examination [24 ] and by ultrasonography (Tringa Linear Vet, Esaote, the Netherlands) to detect (sub)clinical pneumonia. At the end of the animal study all animals were treated topically with amitraz with 2 weeks interval as described above.
Free full text: Click here